Fremd Carlo, Schuetz Florian, Sohn Christof, Beckhove Philipp, Domschke Christoph
Department of Gynecology and Obstetrics; University Hospital of Heidelberg; Heidelberg, Germany.
Oncoimmunology. 2013 Jul 1;2(7):e25443. doi: 10.4161/onci.25443.
The essential role played by T cells in anticancer immunity is widely accepted. The immunosuppressive functions of regulatory T cells are central for tumor progression and have been endowed with a robust predictive value. Increasing evidence indicates that also B cells have a crucial part in the regulation of T-cell responses against tumors. Although experiments reporting the production of natural antitumor antibodies and the induction of cytotoxic immune responses have revealed a tumor-protective function for B cells, other findings suggest that B cells may also exert tumor-promoting functions, resulting in a controversial picture. Here, we review recent evidence on the interactions between B and T cells in murine models and cancer patients and their implications for cancer immunology.
T细胞在抗癌免疫中所起的重要作用已被广泛认可。调节性T细胞的免疫抑制功能对肿瘤进展至关重要,并具有很强的预测价值。越来越多的证据表明,B细胞在调节针对肿瘤的T细胞反应中也起着关键作用。尽管报告天然抗肿瘤抗体产生和细胞毒性免疫反应诱导的实验揭示了B细胞的肿瘤保护功能,但其他研究结果表明,B细胞也可能发挥促肿瘤功能,从而形成了一幅有争议的图景。在这里,我们综述了关于小鼠模型和癌症患者中B细胞与T细胞相互作用的最新证据及其对癌症免疫学的影响。